To download the press release, please click here.
Accelero Launches EliSpot & FluoroSpot GLP Lab Services
Berlin, February 05, 2018
Accelero Bioanalytics GmbH is a GLP certified contract research service provider for regulatory drug development, and maintains biosafety level 2 laboratories in compliance with ICH GCP regulations.
The company is pleased to launch the most sensitive immunoassays currently available on the market. The Enzyme-Linked ImmunoSpot (EliSpot) assay monitors cellular immune response upon stimulation with antigens of interest like monoclonal antibodies, oncolytic viruses, drug product formulations, or even living biotherapeutics like human stem cells or bacterial cells.
Accelero now provides the complete series of routine antibody detection assays (screening, confirmation, neutralization) for primary immunological drug characterization. T-cell or B-cell mediated cytokine secretion can also be detected after isolation from pre-clinical or clinical whole blood samples.
The computerized system can analyse 96-well and 384-well assay plates after standard chromogenic (EliSpot) or 3-colour fluorescence staining (FluoroSpot). The instrument is equipped with a two megapixel camera, and excitation/emission filters for FITC (Alexa488), Cy3, and Cy5 (Alexa647) for parallel staining and detection.
Please follow this link for additional information on our cell-based immunoassays, or use our contact form. Please feel free to send us an email to service(at)accelero-bioanalytics.com. The Accelero team will be happy to assist you.